Edition:
United States

Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

21.00USD
20 Jan 2017
Change (% chg)

$0.30 (+1.45%)
Prev Close
$20.70
Open
$20.75
Day's High
$21.25
Day's Low
$20.70
Volume
617,727
Avg. Vol
648,126
52-wk High
$40.57
52-wk Low
$16.40

Select another date:

Mon, Jan 9 2017

BRIEF-Acorda announces 2016 AMPYRA net sales and 2017 financial guidance

* Acorda announces 2016 AMPYRA net sales and 2017 financial guidance at J.P. Morgan healthcare conference

BRIEF-Acorda to discontinue development of Dalfampridine for treatment of post-stroke walking difficulties

* Milestone clinical study did not show sufficient efficacy to support further development of dalfampridine to improve pswd

BRIEF-Acorda Therapeutics Q3 non-GAAP loss per share $0.04

* Acorda provides financial and pipeline update for third quarter 2016

BRIEF-Acorda Therapeutics presents data from clinical and preclinical trials of CVT-301

* Acorda Therapeutics Inc-presents data from clinical and preclinical trials of CVT-301 for treatment of OFF periods in Parkinson's disease

BRIEF-Arbitral Tribunal confirms Acorda's redemption right regarding Biotie shares

* Arbitral Tribunal confirmed Acorda's redemption right regarding Biotie shares

Select another date: